> top > docs > PubMed:2536585 > annotations

PubMed:2536585 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T1 17-38 D002285 denotes intraductal carcinoma
T2 17-38 D002285 denotes intraductal carcinoma
T5 46-52 UBERON:0000310 denotes breast
T6 102-109 D009369 denotes cancers
T7 102-109 D009369 denotes cancers
T10 111-135 D002285 denotes ductal carcinoma in situ
T11 111-135 D002285 denotes ductal carcinoma in situ
T17 137-141 CVCL_5552 denotes DCIS
T16 137-141 D002285 denotes DCIS
T18 137-141 D002285 denotes DCIS
T21 146-170 D002285 denotes ductal carcinoma in situ
T22 146-170 D002285 denotes ductal carcinoma in situ
T27 326-330 UBERON:0000025 denotes duct
T28 326-330 UBERON:0000058 denotes duct
T29 418-425 D009369 denotes cancers
T30 418-425 D009369 denotes cancers
T31 472-475 PR:Q0VIA1 denotes ten
T32 509-516 D004194 denotes disease
T33 509-516 D004194 denotes disease
T34 564-570 UBERON:0002030 denotes nipple
T35 595-601 D009369 denotes tumors
T36 595-601 D009369 denotes tumors
T38 611-615 CVCL_5552 denotes DCIS
T37 611-615 D002285 denotes DCIS
T39 611-615 D002285 denotes DCIS
T40 632-637 UBERON:0000058 denotes ducts
T41 653-667 D018365 denotes residual tumor
T42 653-667 D018365 denotes residual tumor
T45 721-726 UBERON:0000058 denotes ducts
T46 914-919 UBERON:0000058 denotes ducts
T47 999-1004 PR:000000105 denotes nodal
T48 999-1004 PR:P43021 denotes nodal
T49 999-1004 PR:Q96S42 denotes nodal
T50 999-1004 P43021 denotes nodal
T51 1005-1015 D009362 denotes metastases
T52 1005-1015 D009362 denotes metastases
T53 1043-1049 D009369 denotes tumors
T54 1043-1049 D009369 denotes tumors
T55 1104-1109 UBERON:0000058 denotes ducts
T56 1220-1226 D009369 denotes tumors
T57 1220-1226 D009369 denotes tumors
T58 1276-1282 D009369 denotes tumors
T59 1276-1282 D009369 denotes tumors

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 102-109 HP_0002664 denotes cancers
T2 418-425 HP_0002664 denotes cancers
T3 564-582 HP_0004404 denotes nipple abnormality
T4 595-601 HP_0002664 denotes tumors
T5 662-667 HP_0002664 denotes tumor
T6 1043-1049 HP_0002664 denotes tumors
T7 1220-1226 HP_0002664 denotes tumors
T8 1276-1282 HP_0002664 denotes tumors

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-53 DRI_Unspecified denotes Heterogeneity of intraductal carcinoma of the breast.
T2 54-267 DRI_Background denotes Fifty-one women (29 to 75 years of age) with 55 cancers (ductal carcinoma in situ [DCIS] or ductal carcinoma in situ with microinvasion [DCISM] were studied by comparing biopsy specimens with mastectomy specimens.
T3 268-390 DRI_Background denotes Presentation, histologic type, nuclear grade, microscopic duct counts, multicentricity, and microinvasion were correlated.
T4 391-583 DRI_Background denotes Forty-seven percent of the cancers (26 of 55) were detected by mammography, 18% (ten of 55) were incidental to benign disease, and 35% (19 of 55) were palpable or exhibited nipple abnormality.
T5 584-686 DRI_Approach denotes Incidental tumors were all DCIS, averaged seven ducts, and showed no residual tumor during mastectomy.
T6 687-795 DRI_Outcome denotes Mammographic lesions averaged 117 ducts (31% [eight of 26] were DCISM and 42% [11 of 26] were multicentric).
T7 796-883 DRI_Unspecified denotes Most comedocarcinomas that showed a high incidence of microinvasion were in this group.
T8 884-988 DRI_Outcome denotes Clinical lesions averaged 110 ducts (42% [eight of 19] were DCISM and 68% [13 of 19] were multicentric).
T9 989-1016 DRI_Unspecified denotes Three had nodal metastases.
T10 1017-1176 DRI_Outcome denotes Mammographic and clinical tumors in the quantitative range of the incidental group (50 ducts) showed significant differences from it for all variables studied.
T11 1177-1264 DRI_Background denotes Histologic and quantitative study of these tumors is necessary to best guide treatment.
T12 1265-1319 DRI_Approach denotes Incidental tumors, however, may only need observation.